Literature DB >> 35499703

Human herpes 6 encephalitis in co-infection with Covid-19.

A Di Nora1, F Pizzo2, G Costanza2, M Ruggieri3, R Falsaperla4.   

Abstract

Entities:  

Keywords:  COVID-19; Encephalitis; Herpes virus 6

Year:  2022        PMID: 35499703      PMCID: PMC9058735          DOI: 10.1007/s13760-022-01961-w

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN: 0300-9009            Impact factor:   2.471


× No keyword cloud information.
A 2-year-old-boy presented with ensuing convulsions lasting 40 min (neurological disorders never referred in anamnesis), 3-day history of low-grade fever, erythematous rash on the trunk. Treatment with Midazolam in continuous infusion was started (0.01 mg/kg/h). For the strong suspect of meningoencephalitis, a magnetic resonance imaging (MRI) in emergency was performed, showing an altered signal in temporal lobe (imagine 1), and a lumbar puncture which revealed clear, non-hemorrhagic cerebrospinal fluid (CSF) with 278 cells/µL (70% lymphocytes). The real-time polymerase chain reaction (qPCR) assay from a nasopharyngeal swab revealed the presence of the Sars-Cov2 in the child and the mother. Treatment with intravenous acyclovir (10 mg/kg three times a day) and ceftriaxone (70 mg/kg/day) was started. The analysis of the CSF revealed the presence of HSV-6 DNA by PCR. The antibody title in the blood showed IgM for HSV-6. The immune system was studied revealing that he was an immunocompetent subject. After 2 weeks of treatment with acyclovir, child was discharged in good conditions. After treatment, a control MRI showed a partial disappearance of the strong signal in the temporal lobe precedent described. In children, primary infection with HSV-6 consists in roseola, a self-limited disease characterized by fever, rash, and pharyngitis. Rare cases of encephalitis to HSV-6 have been reported in immunocompetent individuals, all infants younger than 3 years [1]. The damage seems related to the indirect effects of cytokine release rather than from direct viral CNS infection [2]. Thus, a co-infection viral may worse cytokine release and contribute to clinical manifestations. Many neurological manifestations are described in children affected by Covid-19 and some cases reported encephalitis. Although, most of these reports have had normal neuroimaging. Interestingly, a single study reported a neonatal case affected by seizures and MRI suggestive of viral encephalitis [3]. Diverse and different pathophysiological mechanisms behind neurologic manifestations associated with SARS-CoV-2 infection have been supposed. Some authors proposed an immune-mediated mechanism, reporting Guillain–Barré syndrome or acute disseminated encephalomyelitis [4]. Others supposed the possibility of invasion of Sars-Cov19 because the virus binds the surface spike protein to the human angiotensin-converting enzyme 2 receptor (ACE-2) and ACE-2 is present in the brain vascular endothelium [5]. Differently, others correlate the neurologic features with a severe state of inflammation. Our experience contributes to giving value to this last hypothesis. Finally, it is interesting observing that multiple studies have been published regarding coinfections with other respiratory pathogens or bacterial infections among patients with COVID-19 [6]. To date, it is the first case of HSV-6 encephalitis in the context of co-infection with Sars-Cov19. In addition, it is a rare study decribing MRI abnormality in a child with COVID-19-associated encephalitis (Fig. 1).
Fig. 1

MRI of the patient. a Axial T2-weighted MR image (left), b Coronal T2-weighted MR image (right); images show a hyperintense lesion on the insular cortex with swollen appearance (white arrows)

MRI of the patient. a Axial T2-weighted MR image (left), b Coronal T2-weighted MR image (right); images show a hyperintense lesion on the insular cortex with swollen appearance (white arrows)
  6 in total

1.  Human herpesvirus-6 infection in children. A prospective study of complications and reactivation.

Authors:  C B Hall; C E Long; K C Schnabel; M T Caserta; K M McIntyre; M A Costanzo; A Knott; S Dewhurst; R A Insel; L G Epstein
Journal:  N Engl J Med       Date:  1994-08-18       Impact factor: 91.245

2.  Cytokine and chemokine responses in the blood and cerebrospinal fluid of patients with human herpesvirus 6B-associated acute encephalopathy with biphasic seizures and late reduced diffusion.

Authors:  Yoshiki Kawamura; Yumie Yamazaki; Masahiro Ohashi; Masaru Ihira; Tetsushi Yoshikawa
Journal:  J Med Virol       Date:  2013-10-16       Impact factor: 2.327

3.  Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target.

Authors:  Haibo Zhang; Josef M Penninger; Yimin Li; Nanshan Zhong; Arthur S Slutsky
Journal:  Intensive Care Med       Date:  2020-03-03       Impact factor: 17.440

Review 4.  The Complexity of Co-Infections in the Era of COVID-19.

Authors:  Nevio Cimolai
Journal:  SN Compr Clin Med       Date:  2021-04-23

5.  MR Imaging Findings in a Neonate With COVID -19-Associated Encephalitis.

Authors:  Paul J Martin; Marcia Felker; Rupa Radhakrishnan
Journal:  Pediatr Neurol       Date:  2021-03-09       Impact factor: 3.372

6.  Guillain-Barré Syndrome Associated with SARS-CoV-2 Infection in a Pediatric Patient.

Authors:  Carlos Henrique Michiles Frank; Taynná Vernalha Rocha Almeida; Elyana Almeida Marques; Quezia de Sousa Monteiro; Pablo Vinícius Silveira Feitoza; Mayla Gabriela Silva Borba; Heline Lira Vasconcelos; Michele de Souza Bastos; Marcus Vinicius Guimarães Lacerda
Journal:  J Trop Pediatr       Date:  2021-07-02       Impact factor: 1.165

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.